Rutgers Cancer Institution of New Jersey is America’s only National Cancer Institution dedicated to improve detection, treatment and care of patients with cancer and also serve as an education resource for cancer prevention. Physician-scientists at the Institute engage in translational research by transforming the discoveries made in their laboratories into clinical practice. Rutgers University has the ‘18 Chair Challenge’ campaign in which an anonymous donor in 2011, made a pledge of 27 million dollars to create challenge grants for establishment of 18 new endowed chairs. For every 1.5 million dollars raised for a chair meeting the donor’s criteria, the donor will match the gift with an additional 1.5 million dollars needed to endow it. The Omar Boraie Chair in Genomic Science was established and named after the New Brunswick developer Omar Boraie made a 1.5 million dollars to support it. This will help propel research in the field of precision medicine at Rutgers Cancer Institute of New Jersey.
Medical professionals are changing how they approach cancer diagnosis and treatment thanks to the field of genomic science and precision medicine which involves analyzing and treating tumors on a genetic level thus allowing oncologists to prescribe individualized therapies. This results in better outcomes. President Obama even launched a national Precision Medicine Initiative focused on finding a cure for cancer and other diseases in his most recent State of the Union Address, showing how important it is. Precision medicine enables scientists to classify cancer into groups with similar characteristics but different genetics so as to predict patient outcomes better and also come up with individualized cancer therapies.
Omar Boraie who has a background in chemistry and an interest in cancer research hopes that his pledge would motivate others to come forth in the support of precision medicine. He believes the physician-scientists at Rutgers Cancer Institute are making significant advances in the field for those patients whose cancers are no longer responsive to the cancer medication available. Rutgers Cancer Institution Director, Robert S. DiPaola thanks Mr. Boraie’ s generosity and recognizes him as an integral part of the development of New Brunswick as a ‘Healthcare City’. Robert also notes Boraie’s desire to support an endowed chair will have an impact on cancer research and treatment of patients within and without New Brunswick.